[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349806-105":59,"doc-detail-349806-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hoxb5-in-precision-oncology-regulatory-networks-functional-duality-and-clinical-prospects","HOXB5 in precision oncology: regulatory networks, functional duality, and clinical prospects","","HOXB5, a homeobox (HOX) gene family member, shows dysregulated expression across many human cancers, where it associates with malignant progression and inferior clinical outcomes. This review synthesizes HOXB5 regulatory networks and cancer-relevant functions, mapping expression patterns across tumor types and detailing mechanisms involving noncoding RNAs, DNA methylation, histone modifications, phosphorylation, HOX/PBX interactions, NPM1 mutations, RB1 loss, and single-nucleotide polymorphisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hoxb5-in-precision-oncology-regulatory-networks-functional-duality-and-clinical-prospects/349806/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hoxb5-in-precision-oncology-regulatory-networks-functional-duality-and-clinical-prospects/349806.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which HOXB5-related mechanisms does the review summarize?","Question",{"text":112,"@type":113},"The review covers regulatory mechanisms including noncoding RNAs, DNA methylation, histone modifications, phosphorylation events, HOX/PBX interactions, NPM1 mutations, RB1 loss, and single-nucleotide polymorphisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cancer cell behaviors does HOXB5 influence according to the review?",{"text":117,"@type":113},"HOXB5 is described as a central regulatory node that modulates proliferation, migration, invasion, apoptosis, epithelial–mesenchymal transition (EMT), and remodeling of the tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How can HOXB5 act as both oncogene and tumor suppressor?",{"text":121,"@type":113},"The review emphasizes context-dependent dual functions: it predominantly behaves as an oncogene, yet can function as a tumor suppressor in specific settings, such as restraining tumor growth via B-cell conversion into tumor-specific T cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349806,1790193615,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Zhong et al. Journal of Translational Medicine (2026) 24:133  \n[https://doi.org/10.1186/s12967-025-07654-1](https://doi.org/10.1186/s12967-025-07654-1)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nHOXB5 in precision oncology: regulatory networks, functional duality, and clinical prospects  \nKui Zhong1†, Qiang Yi1, Zheng Chen1, Yongchang Xu1, Yangneng Zeng2 and Jinghua Zhong3,4,5,6*  \nAbstract  \nBackground HOXB5, a member of the homeobox (HOX) gene family. Its dysregulated expression has been increasingly reported across multiple human cancers, where it correlates with malignant progression and poor clinical outcomes. A concise synthesis of its regulatory networks and cancer-associated functions is therefore needed to clarify its biological and translational significance.  \nMain body This review summarizes the expression landscape of HOXB5 across diverse tumor types and delineates its key regulatory mechanisms, including noncoding RNAs, DNA methylation, histone modifications, phosphorylation events, HOX/PBX interactions, NPM1 mutations, RB1 loss, and single-nucleotide polymorphisms. Functionally, HOXB5 acts as a central regulatory node that integrates multiple signaling pathways to modulate cancer cell proliferation, migration, invasion, apoptosis, epithelial–mesenchymal transition (EMT), and remodeling of the tumor microenvironment. Notably, HOXB5 displays context-dependent dual functions in cancer, acting predominantly asan oncogene but serving as a tumor suppressor in specific settings. For example, HOXB5 can restrain tumor growth by driving B-cell conversion into tumor-specific T cells, while loss of the chromatin remodelers Arid4a/Arid4b reduces HOXB5 expression and may accelerate the progression of certain myeloid disorders to AML.  \nConclusions HOXB5 functions as either an oncogene or a tumor suppressor in a context-dependent manner, and it holds substantial potential as a diagnostic, prognostic, and therapeutic target.  \nKeywords HOXB5 transcription factor oncogene tumor suppressor gene epigenetic regulation clinical significance  \n†Kui Zhong contributed equally to this work.  \n*Correspondence: Jinghua Zhong [m18770738786@163.com](m18770738786@163.com)  \n1The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi Province 341000, China  \n2School of Basic Medical Sciences, Gannan Medical University, Ganzhou, Jiangxi Province 341000, China  \n3Department of Oncology, The First Affiliated Hospital of Gannan Medical University, 128 Jinling Road, Ganzhou, Jiangxi Province 341000, China 4Jiangxi“Flagship” Oncology Department of Synergy for Chinese and Western Medicine, Ganzhou, Jiangxi Province 341000, China  \n5Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development, Ganzhou, Jiangxi Province 341000, China  \n6Jiangxi Clinical Research Center for Cancer, Ganzhou,  \nJiangxi Province 341000, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)","cbCaipVxcnNFjuei","https://ap.wps.com/l/cbCaipVxcnNFjuei","pdf",2753915,"English","# Abstract\n## Background\n## Main body\n## Conclusions\n# Introduction","[{\"question\":\"Which HOXB5-related mechanisms does the review summarize?\",\"answer\":\"The review covers regulatory mechanisms including noncoding RNAs, DNA methylation, histone modifications, phosphorylation events, HOX/PBX interactions, NPM1 mutations, RB1 loss, and single-nucleotide polymorphisms.\"},{\"question\":\"What cancer cell behaviors does HOXB5 influence according to the review?\",\"answer\":\"HOXB5 is described as a central regulatory node that modulates proliferation, migration, invasion, apoptosis, epithelial–mesenchymal transition (EMT), and remodeling of the tumor microenvironment.\"},{\"question\":\"How can HOXB5 act as both oncogene and tumor suppressor?\",\"answer\":\"The review emphasizes context-dependent dual functions: it predominantly behaves as an oncogene, yet can function as a tumor suppressor in specific settings, such as restraining tumor growth via B-cell conversion into tumor-specific T cells.\"}]","HOXB5 in precision oncology: regulatory networks, functional duality, and clinical prospects | PDF",1790085662,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7916ae20d6ed33bc73b742872446917.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c09dd28f1bb1c5f199a5e78e03b13ec9.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9fcd0e805f12ffab09c0d5e1fcd4d37.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8ef61691938c0a24536661c4a98589a.webp",980,1306]